These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12164939)

  • 81. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients.
    Menter A; Cordoro KM; Davis DMR; Kroshinsky D; Paller AS; Armstrong AW; Connor C; Elewski BE; Gelfand JM; Gordon KB; Gottlieb AB; Kaplan DH; Kavanaugh A; Kiselica M; Kivelevitch D; Korman NJ; Lebwohl M; Leonardi CL; Lichten J; Lim HW; Mehta NN; Parra SL; Pathy AL; Farley Prater EA; Rupani RN; Siegel M; Stoff B; Strober BE; Wong EB; Wu JJ; Hariharan V; Elmets CA
    J Am Acad Dermatol; 2020 Jan; 82(1):161-201. PubMed ID: 31703821
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Purification and characterization of an adenosine cyclic 3':5' monophosphate-dependent protein kinase from human erythrocyte membrane.
    Boivin P; Galand C
    Biochem Biophys Res Commun; 1978 Mar; 81(2):473-80. PubMed ID: 208524
    [No Abstract]   [Full Text] [Related]  

  • 83. Generalized pustular psoriasis in a child.
    van de Kerkhof PC
    Dermatologica; 1985; 170(5):244-8. PubMed ID: 4007219
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Combination of etretinate with cyclosporine in the treatment of severe recalcitrant psoriasis.
    Brechtel B; Wellenreuther U; Toppe E; Czarnetzki BM
    J Am Acad Dermatol; 1994 Jun; 30(6):1023-4. PubMed ID: 8188867
    [No Abstract]   [Full Text] [Related]  

  • 85. A corticosteroid-induced flare of psoriasis. How to control or, better yet, avoid.
    Brodell RT; Williams L
    Postgrad Med; 1999 Dec; 106(7):31-2. PubMed ID: 10608962
    [No Abstract]   [Full Text] [Related]  

  • 86. Two cases of generalized pustular psoriasis complicated by IgG4-related disease.
    Miyazawa H; Fujita Y; Iwata H; Ishikawa Y; Nishio S; Ishijima K; Shinmei Y; Takeichi T; Goto K; Oi R; Akiyama M; Shimizu H
    Br J Dermatol; 2018 Aug; 179(2):537-539. PubMed ID: 29709076
    [No Abstract]   [Full Text] [Related]  

  • 87. Adenosine 3',5'-cyclic monophosphate binding sites.
    Haley BE
    Methods Enzymol; 1977; 46():339-46. PubMed ID: 198632
    [No Abstract]   [Full Text] [Related]  

  • 88. Cyclic 3',5'-adenosine monophosphate-dependent protein kinase of skin. II. Levels in atopic dermatitis and psoriasis.
    Mier PD; van den Hurk J; Holla SW; Hollman EP; Porters JE; Weemers MB
    Br J Dermatol; 1972 Dec; 87(6):577-9. PubMed ID: 4346250
    [No Abstract]   [Full Text] [Related]  

  • 89. Human in vivo phosphorus 31 magnetic resonance spectroscopy of psoriasis. A noninvasive tool to monitor response to treatment and to study pathophysiology of the disease.
    Zemtsov A; Dixon L; Cameron G
    J Am Acad Dermatol; 1994 Jun; 30(6):959-65. PubMed ID: 8188887
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Temporomandibular arthritis in a patient with psoriasis vulgaris under systemic etretinate therapy.
    Yamamoto T; Watanabe K; Nishioka K
    Dermatology; 2004; 209(1):77. PubMed ID: 15237278
    [No Abstract]   [Full Text] [Related]  

  • 91. Altered expression of the alpha2 laminin chain in psoriatic skin: the effect of treatment with cyclosporin.
    Toti P; Pellegrino M; Villanova M; Flori ML; Miracco C; Bartolommei S; Andreassi L
    Br J Dermatol; 1998 Sep; 139(3):375-9. PubMed ID: 9767280
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Testing of retinoids for systemic and topical use in human psoriasis and other disorders of keratinization: mouse papilloma test.
    Teelmann K
    Methods Enzymol; 1990; 190():382-95. PubMed ID: 2087190
    [No Abstract]   [Full Text] [Related]  

  • 93. Photoaffinity labeling of adenosine 3',5'-cyclic monophosphate binding sites of human red cell membranes.
    Haley BE
    Biochemistry; 1975 Aug; 14(17):3852-7. PubMed ID: 169887
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Are retinoids active in the treatment of psoriatic rheumatism?].
    Bussière JL; Ristori JM
    Presse Med; 1988 Mar; 17(11):509-11. PubMed ID: 2965358
    [No Abstract]   [Full Text] [Related]  

  • 95. [Retinoids and their metabolism: new therapeutic approaches?].
    Baron JM; Skazik C; Merk HF
    Hautarzt; 2008 Sep; 59(9):745-6. PubMed ID: 18769954
    [No Abstract]   [Full Text] [Related]  

  • 96. Cyclic AMP and cyclic AMP-dependent protein kinase in mouse skin. II. In vitro effects of isotretinoin and etretinate.
    Holian O; Kumar R
    Arch Dermatol Res; 1985; 278(2):161-4. PubMed ID: 3006609
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cyclosporin in less common immune-mediated skin diseases.
    Ruzicka T
    Br J Dermatol; 1996 Sep; 135 Suppl 48():40-2. PubMed ID: 8881904
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Is the cyclic AMP in psoriatic epidermis low?
    Yoshikawa K; Adachi K; Halprin KM; Levine V
    Br J Dermatol; 1975 Sep; 93(3):253-8. PubMed ID: 172103
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Thrombocytopenia possibly induced by etretinate in a psoriatic patient.
    Seishima M; Oda M; Yamanaka S
    J Dermatol; 2005 Nov; 32(11):917-20. PubMed ID: 16361755
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Evaluation of psoriatic patients with HCV infection.
    Yamamoto T; Yokozeki H; Nishioka K
    J Dermatol; 2005 Sep; 32(9):769-70. PubMed ID: 16361725
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.